(Q44025623)

English

The effect of 5 years of annual treatment with ivermectin (Mectizan) on the prevalence and morbidity of onchocerciasis in the village of Gami in the Central African Republic

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

The effect of 5 years of annual treatment with ivermectin (Mectizan) on the prevalence and morbidity of onchocerciasis in the village of Gami in the Central African Republic (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

0 references

0 references

1 reference

based on heuristic

inferred from title

Central African Republic

1 reference

based on heuristic

inferred from title

author name string

Kennedy MH

1

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Bertocchi I

2

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Hopkins AD

3

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Meredith SE

4

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 April 2002

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Annals of Tropical Medicine and Parasitology

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

96

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

297-307

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Onchocercal eye disease and the impact of Mectizan treatment

1 reference

https://api.crossref.org/works/10.1179%2F000349802125000736

21 January 2018

Reduction in incidence of optic nerve disease with annual ivermectin to control onchocerciasis.

1 reference

https://api.crossref.org/works/10.1179%2F000349802125000736

21 January 2018

The impact of five years of annual ivermectin treatment on skin microfilarial loads in the onchocerciasis focus of Asubende, Ghana

1 reference

https://api.crossref.org/works/10.1179%2F000349802125000736

21 January 2018

The effects of ivermectin on onchocercal skin disease and severe itching: results of a multicentre trial

1 reference

https://api.crossref.org/works/10.1179%2F000349802125000736

21 January 2018

Ivermectin treatment of onchocercal skin lesions: observations from a placebo-controlled, double-blind trial in Malawi

1 reference

https://api.crossref.org/works/10.1179%2F000349802125000736

21 January 2018

Low level ivermectin coverage and the transmission of onchocerciasis.

1 reference

https://api.crossref.org/works/10.1179%2F000349802125000736

21 January 2018

Effect of repeated ivermectin treatments on ocular onchocerciasis: evaluation after six to eight doses

1 reference

https://api.crossref.org/works/10.1179%2F000349802125000736

21 January 2018

Changes in ocular onchocerciasis after two rounds of community-based ivermectin treatment in a holo-endemic onchocerciasis focus

1 reference

https://api.crossref.org/works/10.1179%2F000349802125000736

21 January 2018

The effects of multiple doses of ivermectin on ocular onchocerciasis. A six-year follow-up

1 reference

https://api.crossref.org/works/10.1179%2F000349802125000736

21 January 2018

Effects of repeated ivermectin treatment in onchocerciasis.

1 reference

https://api.crossref.org/works/10.1179%2F000349802125000736

21 January 2018

Irreversible effects of ivermectin on adult parasites in onchocerciasis patients in the Onchocerciasis Control Programme in West Africa.

1 reference

https://api.crossref.org/works/10.1179%2F000349802125000736

21 January 2018

Blindness and visual impairment in a region endemic for onchocerciasis in the Central African Republic

1 reference

https://api.crossref.org/works/10.1179%2F000349802125000736

21 January 2018

Longitudinal study of lesions of the posterior segment in onchocerciasis.

1 reference

https://api.crossref.org/works/10.1179%2F000349802125000736

21 January 2018

Effects of repeated doses of ivermectin on ocular onchocerciasis: community-based trial in Sierra Leone

1 reference

https://api.crossref.org/works/10.1179%2F000349802125000736

21 January 2018

A community trial of ivermectin for onchocerciasis in Sierra Leone: clinical and parasitological responses to four doses given at six-monthly intervals

1 reference

https://api.crossref.org/works/10.1179%2F000349802125000736

21 January 2018

Visual loss in an onchocerciasis endemic community in Sierra Leone

1 reference

https://api.crossref.org/works/10.1179%2F000349802125000736

21 January 2018

Improvement in severe onchocercal skin disease after a single dose of ivermectin

1 reference

https://api.crossref.org/works/10.1179%2F000349802125000736

21 January 2018

Clinical and parasitological responses after up to 6.5 years of ivermectin treatment for onchocerciasis.

1 reference

https://api.crossref.org/works/10.1179%2F000349802125000736

21 January 2018

Identifiers

10.1179/000349802125000736

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44025623&oldid=2105750673"